Lanphier High Res (1).jpeg

Elizabeth Lanphier

Assistant Professor in the Ethics Center at Cincinnati Children’s Hospital Medical Center and Division of General and Community Pediatrics, University of Cincinnati
Chapter Member: Central Ohio SSN
Areas of Expertise:

Connect with Elizabeth

About Elizabeth

Lanphier is a moral philosopher and clinical ethicist specializing. Her scholarship is centered around shared and collective responsibility, especially related to health care justice. Lanphier’s research focuses on projects related to health care access, reproductive justice, medical and sexual consent and decision-making, trauma informed care, narrative practices in medicine, incarceration and health, and clinical ethics consultation. In addition to her research and scholarship, Lanphier is a clinical ethics consultant at Cincinnati Children’s Hospital Medical Center, providing ethical support and analysis in direct patient care.

In the News

Opinion: "Vaccine Guilt Is Good – As Long It Doesn’t Stop You From Getting a Shot," Elizabeth Lanphier, The Conversation, April 7, 2021.
Opinion: "Ohio’s Vaccination Plan Used To Include Incarcerated People. Now It Doesn’t," Elizabeth Lanphier, The Enquirerer, March 25, 2021.
Opinion: "Prisoners, at Great Risk, Should Get Vaccine Early the Columbus Dispatch," Elizabeth Lanphier, The Columbus Dispatch, December 21, 2020.
Opinion: "Where No Lives Matter," Elizabeth Lanphier, The Philosophical Salon, August 3, 2020.
Opinion: "Bill Lee’s Pro-Life Message Is Contradicted by Death Penalty Stance," Elizabeth Lanphier, Tennessean, July 31, 2020.


"Over-the-Counter Oral Contraceptives in the Context of State Abortion Bans" (with Hunter Jackson Smith and Jake Earl). Journal of General Internal Medicine (2023).

Discusses the FDA's approval of Opill, a progestin-only norgestrel tablet, for over-the-counter (OTC) access. Emphasizes that while OTC oral contraceptives can enhance accessibility and decrease unplanned pregnancies, they are not a complete solution to post-Dobbs abortion restrictions. Argues that clinicians must maximize the benefits of OTC contraceptives while continuing to advocate for safe and accessible abortion care.